Search
for
Sort by
Research 91–120 of 1000+
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Review of the Literature: Topical JAK Inhibitors Showing Promise for Hair Loss!
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- A case of refractory alopecia areata successfully treated by combining delgocitinib ointment with excimer laser
- Drug Armamentarium for alopecia areata
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Evidence for the off-label use of tofacitinib in alopecia areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- A retrospective review of paediatric alopecia areata cases seen in a tertiary institution in Singapore
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata
- Beyond the follicle
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors